Erschienen in:
03.06.2019 | Health Services Research and Global Oncology
Resolve the Conflict Rather than Dissolve the Relationship
verfasst von:
Sandra L. Wong, MD, MS, Steven C. Stain, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 8/2019
Einloggen, um Zugang zu erhalten
Excerpt
In this issue of
Annals of Surgical Oncology, Santamaria-Barria and colleagues
1 examined the extent of industry funding for surgical oncologists, based on reports made to the Centers for Medicare and Medicaid Services Open Payments Program. Nearly 18% of Society of Surgical Oncology members in academic practice received over $46.6 million in research funding over 4 years. Interestingly, the vast majority (87%) of payments were related to studies of novel pharmaceuticals and not surgical devices. The authors include contemporary comparison data to illustrate the concomitant trends in federal funding, demonstrating a positive correlation to those with industry funding, especially among those in the top quartile of industry funding. By nature of the data presented, it is unknown if the association between industry funding and other measures of academic success (whether measured by publications or National Institutes of Health [NIH] funding) is a causal association or if industry is more apt to fund already successful academic surgeons. …
